Eko Analysis Software vs Eko Low Ejection Fraction Tool (ELEFT)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 80/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Eko Devices
VS

AI Verdict

Eko Analysis Software provides broader AI-powered detection for heart murmurs and atrial fibrillation, suitable for general cardiovascular screening and remote monitoring. The Eko Low Ejection Fraction Tool (ELEFT) is specifically designed for the early identification of low ejection fraction, a key indicator of heart failure, and is positioned as an enterprise solution. While both leverage Eko's stethoscope technology for cardiovascular AI, their primary diagnostic focuses and target deployment models differ.

Choose Eko Analysis Software if…

Choose Eko Analysis Software if your primary need is a versatile AI-powered tool for broad cardiovascular screening during routine exams. This software is ideal for clinicians seeking early detection of common conditions like heart murmurs and atrial fibrillation, along with comprehensive capabilities for recording, visualizing, and annotating heart sounds and ECGs for detailed patient assessment and longitudinal tracking.

View Eko Analysis Software →

Choose Eko Low Ejection Fraction Tool (ELEFT) if…

Choose Eko Low Ejection Fraction Tool (ELEFT) if your focus is specifically on the early identification of heart failure risk in patients. This specialized AI algorithm is best suited for clinicians who need a rapid, non-invasive screening tool to detect low ejection fraction during routine physical exams, enabling proactive management for patients at risk of developing heart failure.

View Eko Low Ejection Fraction Tool (ELEFT) →

When choosing between Eko Analysis Software and the Eko Low Ejection Fraction Tool (ELEFT), physicians should consider their primary diagnostic focus and practice setting. Eko Analysis Software is a versatile tool best suited for general cardiovascular screening, offering FDA-cleared AI for the detection of heart murmurs and atrial fibrillation (AFib), as well as normal sinus rhythm and cardiac time intervals. This makes it ideal for individual clinicians in various specialties like cardiology, emergency medicine, and internal medicine who need a broad overview of a patient’s heart health during routine exams.

In contrast, the Eko Low Ejection Fraction Tool (ELEFT) is a specialized AI algorithm designed specifically for the early detection of low ejection fraction (LVEF ≤ 40%), a key indicator of heart failure. ELEFT is integrated into Eko’s SENSORA™ platform, an enterprise solution, and is particularly valuable for health systems and practices with a focused need for heart failure screening in at-risk populations. The key practical difference lies in their scope: Eko Analysis Software provides a broader set of cardiac insights, while ELEFT offers a targeted, rapid assessment for a specific, critical condition.

Therefore, a physician seeking a comprehensive, individual-provider-focused tool for general cardiovascular screening, including murmurs and AFib, would likely choose Eko Analysis Software, which operates on a freemium model with a subscription for full features. For health systems or specialists primarily focused on identifying heart failure risk through low ejection fraction detection, ELEFT, as part of the SENSORA™ enterprise platform, would be the more appropriate choice, requiring direct contact with Eko Health for pricing and deployment.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Eko Analysis Software Eko Low Ejection Fraction Tool (ELEFT)
Pricing Freemium with subscription for full features Contact for pricing
Deployment Cloud-based Cloud-based software integrated with Eko digital stethoscopes.
FDA Status 1 AI-estimated 1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Analysis Software

Eko Analysis Software offers a broader set of user-facing features, including a mobile app, recording, playback, and visualization of heart sounds and ECGs, suggesting a more comprehensive and versatile user experience. Its freemium model also provides an accessible entry point for individual users to explore its functionalities.

Clinical Value

Eko Analysis Software

Eko Analysis Software provides FDA-cleared AI for the detection of both heart murmurs and atrial fibrillation, along with normal sinus rhythm and cardiac time intervals, covering a wider range of common cardiovascular conditions. While ELEFT targets the critical indicator of low ejection fraction, Tool A's broader diagnostic assistance offers more frequent clinical utility across a larger patient population.

Pricing & Value

Eko Analysis Software

Eko Analysis Software features a transparent freemium model with clear subscription tiers for full AI capabilities and telehealth. This offers greater accessibility and allows users to experience basic features before committing to a paid plan. ELEFT, being an 'enterprise solution' with 'contact for pricing,' suggests a higher, less transparent cost structure.

Enterprise Readiness

Eko Low Ejection Fraction Tool (ELEFT)

The Eko Low Ejection Fraction Tool (ELEFT) is explicitly stated to be 'part of Eko's SENSORAu2122 platform, an enterprise solution,' indicating it is specifically designed and packaged for larger organizational deployments. While Eko Analysis Software is cloud-based and HIPAA compliant, ELEFT's explicit enterprise designation gives it an edge in this dimension.

Innovation

Tie

Both tools demonstrate significant innovation by leveraging FDA-cleared AI to enhance cardiac auscultation for early disease detection. Eko Analysis Software offers a broader range of AI-powered detections (murmurs, AFib) and comprehensive data visualization. ELEFT's rapid (15-second) AI detection of low ejection fraction, a key heart failure indicator, is also a highly impactful innovation.

Support & Docs

Tie

Both tools are products of Eko Health and are supported by a common 'Help Center' that provides user manuals, FAQs, and contact options for technical support, as confirmed by web search. There is no differentiating information to suggest one tool has superior support or documentation over the other.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Eko Analysis Software Eko Low Ejection Fraction Tool (ELEFT)
Name Eko Analysis Software Eko Low Ejection Fraction Tool (ELEFT)
Company Eko Devices Eko Health
Primary AI Detection Focus FDA-cleared AI for heart murmur detection, FDA-cleared AI for atrial fibrillation (AFib) detection, Detection of normal sinus rhythm AI-powered low ejection fraction detection
Other Key Features Calculation of cardiac time intervals (heart rate, QRS duration), Wireless auscultation with Bluetooth-enabled devices, Recording, playback, and annotation of heart sounds and ECGs, Visualization of phonocardiograms (PCG) and ECG tracings, Secure cloud-based storage of recordings within the US Integrates with FDA-cleared Eko digital stethoscopes, Analyzes ECG and heart sound recordings, Provides results in approximately 15 seconds, Part of the SENSORAu2122 Cardiac Early Detection Platform, Cloud-based data processing and storage, Aids in early identification of heart failure risk, Non-invasive screening tool
Specialties Cardiology, Emergency Medicine, Internal Medicine Cardiology, Family Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring Eko Analysis Software and Eko Low Ejection Fraction Tool (ELEFT).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Eko Analysis Software is designed to assist clinicians in the early detection of heart murmurs and atrial fibrillation, as well as detecting normal sinus rhythm and calculating cardiac time intervals. The Eko Low Ejection Fraction Tool (ELEFT) is specifically an AI algorithm to aid in the early detection of low ejection fraction, which is a key indicator of heart failure.
Eko Analysis Software operates on a freemium model, where basic app features are free, but an Eko+ membership is required for full AI-powered detection capabilities, saving recordings, patient profiles, and PDF reports. ELEFT is part of Eko's SENSORAu2122 platform, which is an enterprise solution, and specific pricing requires contacting Eko Health sales.
Eko Analysis Software offers recording, playback, and annotation of heart sounds and ECGs, along with visualization of phonocardiograms (PCG) and ECG tracings, and the ability to generate PDF reports with an Eko+ membership. ELEFT specifically analyzes ECG and heart sound recordings to provide AI-powered low ejection fraction detection results in approximately 15 seconds.
The Eko Low Ejection Fraction Tool (ELEFT) is explicitly stated to be part of Eko's SENSORAu2122 Cardiac Early Detection Platform, which is an enterprise solution. Eko Analysis Software integrates with Eko's digital stethoscopes and mobile app, offering various features through its own application.
Eko Analysis Software is listed for Cardiology, Emergency Medicine, and Internal Medicine. ELEFT is listed for Cardiology, Family Medicine, and Internal Medicine, indicating a slight difference in the targeted broader clinical settings.
The Eko Low Ejection Fraction Tool (ELEFT) provides its AI-powered low ejection fraction detection results in approximately 15 seconds. Eko Analysis Software does not specify a precise time for its AI detection results for heart murmurs or AFib, but it offers real-time visualization and recording capabilities.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.